Announcement on the Holding Subsidiary Obtaining Medical Device Registration Certificate
September 18, 2025
Source: drugdu
113
September 17th, Meikang BioAccording to the announcement, the company's holding subsidiary Jiangxi Meikang Shengde Biotechnology Co., Ltd. recently obtained the " Medical Device Certificate of the People's Republic of China" issued by the Jiangxi Provincial Drug Administration.Registration Certificate ( In Vitro DiagnosticThe product names are: tissue plasminogen activator-inhibitor 1 complex detection kit (chemiluminescent immunoassay), thrombin-antithrombin complex detection kit (chemiluminescent immunoassay), thrombomodulin detection kit (chemiluminescent immunoassay), plasmin-α2 plasmin inhibitor complex detection kit (chemiluminescent immunoassay).
https://finance.eastmoney.com/a/202509173516207639.html
By editor
Copyright©2025 Ddu. All rights reserved.
Read more on
- Breaking the Mold and Forging a New Path! From Insulin Technology Pioneer to Global Innovation Competitor December 4, 2025
- A subsidiary of Kingfriend Pharmaceutical Co., Ltd. has received FDA approval for its self-developed injectable dapavancin December 4, 2025
- Major ophthalmic new drug successfully completed Phase III trials December 4, 2025
- Simcere Pharmaceutical and Wangshan Wangshui have reached an exclusive licensing agreement for deuterium remidevir hydrobromide for new indications such as RSV infection December 4, 2025
- SAL0140 tablets approved for clinical trials for the treatment of chronic kidney disease December 4, 2025
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
